FENNEC PHARMACEUTICALS INC. - FENC

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Feb 17, 2026 SCHEDULE 13G/A Sonic Fund II, L.P. 7.6% 2,607,357 View
Feb 17, 2026 SCHEDULE 13G/A Sonic GP LLC 7.6% 2,607,357 View
Feb 17, 2026 SCHEDULE 13G/A Kam Lawrence 8.2% 2,799,959 View
Feb 11, 2026 SCHEDULE 13G/A Rosalind Advisors, Inc. 9.8% 2,746,840 View
Feb 11, 2026 SCHEDULE 13G/A SALAMON STEVEN A J 9.5% 2,680,174 View
Feb 11, 2026 SCHEDULE 13G/A Aharon Gil 9.5% 2,680,174 View
Feb 11, 2026 SCHEDULE 13G/A Rosalind Master Fund L.P. 9.3% 2,613,508 View
Jan 14, 2026 SCHEDULE 13G/A Southpoint Master Fund, LP 8.0% 2,744,741 View
Jan 14, 2026 SCHEDULE 13G/A Southpoint Capital Advisors LP 8.0% 2,744,741 View
Jan 14, 2026 SCHEDULE 13G/A Southpoint Capital Advisors LLC 8.0% 2,744,741 View
Jan 14, 2026 SCHEDULE 13G/A Southpoint GP, LP 8.0% 2,744,741 View
Jan 14, 2026 SCHEDULE 13G/A Southpoint GP, LLC 8.0% 2,744,741 View
Jan 14, 2026 SCHEDULE 13G/A John S. Clark II 8.0% 2,744,741 View
Nov 13, 2025 SCHEDULE 13G Rosalind Advisors, Inc. 7.5% 2,076,840 View
Nov 13, 2025 SCHEDULE 13G SALAMON STEVEN A J 7.5% 2,076,840 View
Nov 13, 2025 SCHEDULE 13G Aharon Gil 7.5% 2,076,840 View
Nov 13, 2025 SCHEDULE 13G Rosalind Master Fund L.P. 7.5% 2,076,840 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.